StockStory.org on MSN

Corcept (NASDAQ:CORT) Reports Sales Below Analyst Estimates In Q3 Earnings

Biopharma company Corcept Therapeutics (NASDAQ:CORT) in Q3 CY2025, but sales rose 13.7% year on year to $207.6 million. The ...
Hosted on MSN

AIG (NYSE:AIG) Delivers Impressive Q3

Find out by accessing our full research report, it’s free for active Edge members. With roots dating back to 1919 ... more ...